Aaron B Jolley, in Clackamas, OR - Licensed Practical Nurse

Aaron B Jolley, is a Licensed Practical Nurse based in Clackamas, Oregon. Aaron B Jolley is licensed to practice in Oregon (license number 200530050LPN) and his current practice location is 9800 Se Sunnyside Rd, Clackamas, Oregon. He can be reached at his office (for appointments etc.) via phone at (503) 572-9449.

NPI number for Aaron B Jolley is 1912133604 and his current mailing address is 326 Nw 207th Ave, Beaverton, Oregon. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1912133604.

Contact Information

	Aaron B Jolley,
	9800 Se Sunnyside Rd, Clackamas, OR 97015-9750
	(503) 572-9449
	Not Available

Provider's Profile

Full Name	Aaron B Jolley
Gender	Male
Speciality	Licensed Practical Nurse
Location	9800 Se Sunnyside Rd, Clackamas, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1912133604
Provider Enumeration Date: 06/08/2009
Last Update Date: 06/08/2009

Medical Identifiers

Medical identifiers for Aaron B Jolley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912133604	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	200530050LPN (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aaron B Jolley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Aaron B Jolley, 326 Nw 207th Ave, Beaverton, OR 97006-2186 Ph: (360) 710-4772	Aaron B Jolley, 9800 Se Sunnyside Rd, Clackamas, OR 97015-9750 Ph: (503) 572-9449

News Archive

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.

New approach to find tailored treatments for adolescent depression

Depression is on the rise among adolescents in the United States; in fact, according to the NIH, an estimated 3.2 million U.S. teenagers experience major depression each year.

H. pylori infection could play a role in Parkinson's disease development

The stomach bacteria responsible for ulcers could also play a role in the development of Parkinson's disease according to research presented today at the 111th General Meeting of the American Society for Microbiology.

PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).

Friday opinions: Mandate to buy insurance; Medicare and 'political game'

If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).

Aaron B Jolley, - Licensed Practical Nurse in Clackamas, OR